THERAPEUTIC IMPLICATIONS OF BIOAVAILABILITY

被引:8
作者
AZARNOFF, DL
HUFFMAN, DH
机构
[1] UNIV KANSAS,MED CTR,DEPT MED,KANSAS CITY,KS 66103
[2] UNIV KANSAS,MED CTR,DEPT PHARMACOL,KANSAS CITY,KS 66103
[3] VET ADM HOSP,KANSAS CITY,MO 64128
关键词
D O I
10.1146/annurev.pa.16.040176.000413
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:53 / 66
页数:14
相关论文
共 128 条
[21]  
CARTER AK, 1963, CAN MED ASSOC J, V88, P98
[22]   CLINICALLY INACTIVE THYROID USP - A PRELIMINARY REPORT [J].
CATZ, B ;
GINSBURG, E ;
SALENGER, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1962, 266 (03) :136-&
[23]   PLASMA DIGOXIN CONCENTRATIONS IN PATIENTS WITH ATRIAL FIBRILLATION [J].
CHAMBERLAIN, DA ;
WHITE, RJ ;
HOWARD, MR ;
SMITH, TW .
BMJ-BRITISH MEDICAL JOURNAL, 1970, 3 (5720) :429-+
[24]   THE RELATION BETWEEN INVITRO DISINTEGRATION TIME OF SUGAR-COATED TABLETS AND PHYSIOLOGICAL AVAILABILITY OF RIBOFLAVIN [J].
CHAPMAN, DG ;
CRISAFIO, R ;
CAMPBELL, JA .
JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION-SCIENTIFIC EDITION, 1954, 43 (05) :297-304
[25]   BIOAVAILABILITY OF DRUGS FROM FORMULATIONS AFTER ORAL-ADMINISTRATION [J].
CHASSEAUD, LF ;
TAYLOR, T .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1974, 14 :35-46
[26]   CONCENTRATION OF ANTIBACTERIAL AGENTS IN INTERSTITIAL TISSUE FLUID [J].
CHISHOLM, GD ;
WATERWORTH, PM ;
CALNAN, JS ;
GARROD, LP .
BMJ-BRITISH MEDICAL JOURNAL, 1973, 1 (5853) :569-573
[27]  
CLAPPER WILLIAM E., 1960, ANTIBIOT MED AND CLIN THER, V7, P91
[28]  
CORBUS H F, 1964, Calif Med, V100, P364
[30]  
Davies R O, 1972, Can Med Assoc J, V107, P183